Executive Team

Ben Ward

Chief Executive Officer

Ben leads all facets of the company’s operations, including its strategic direction and execution, finance and industry relations. He brings extensive domestic and global experience in business development, infrastructure development and capital markets to his leadership of Wayland. Ben holds a BA from Heritage College and an MBA from Bradford University School of Management (England), the latter with a dual concentration in Operations and Finance.

Bhupinder Brar

Chief Strategy Officer

Bhupinder has over a decade of experience working in the pharmaceutical and telecommunications industries, developing long-term business strategies in Canada, Europe and International markets. As a Certified Management Accountant (CPA, CMA), Bhupinder brings a wealth of financial expertise to the company, specializing in capital management, M&A, and internal financial planning. With an MBA from Wilfrid Laurier University, he drives strategic performance as Chief Strategy Officer at Wayland Group Inc.

Geoff Kosar

Vice President Sales & Marketing

Geoff has played a key role in shaping the marketing and strategic direction of many iconic household brands in Canada for the past 20 years. Most recently, he was the Head of Marketing at Diageo, Canada’s largest Spirits company. Geoff understands selling and marketing brands in regulated industries.

Terry Fretz

President

Terry Fretz is a long-time pharmaceutical executive, Terry was integral in establishing and running two privately held generic pharmaceutical companies. Under his leadership, both organizations were recognized as the fastest growing pharma companies in Canada. Both companies were subsequently acquired by publicly traded multinationals. Terry served as President and General Manager of Watson Pharmaceuticals - Canada before assuming his responsibilities as President at Wayland.

Scott Langille

Chief Financial Officer

Scott has over 30 years of experience in the pharmaceutical industry in both Canada and the United States. Scott has held CFO positions at publicly traded pharmaceutical companies including Tribute Pharmaceuticals, and Virexx Medical Corp. Past financial experience includes Vice President at Biovail Pharmaceuticals Inc. and Director, Corporate Finance at Biovail Corporation. Scott has a professional accounting designation and an MBA from the University of Toronto.

Morten Brandt

General Manager, Europe

Internationally experienced Executive in Healthcare. 15 years experience in pharmaceutical General Management roles. Previous roles: Vice President Medium Sized Markets – Norgine. Managing company affiliates in Europe, MENA and South Africa, Management of Distributor relationships in South East Asia, Europe and MENA, General Manager / Vice President Germany, Austria, Switzerland – Norgine, Sales & Marketing Director Germany & Austria, Finance and Admin roles. Longstanding active member in German Pharmaceutical Industry Association (Bundesverband der pharmazeutischen Industrie, BPI). Long-standing board member in Regional Board of the BPI in Hessen.

Matt McLeod

General Counsel

Matt was called to the Ontario bar in 2013 and the New York bar in 2014, holds a BEng and an MBA from the Royal Military College of Canada as well as a JD from Western University. Matt started his legal career as a corporate lawyer with Osler, Hoskin & Harcourt LLP in New York City and has significant experience providing corporate structure and commercial support to various organizations, including leading the legal group at a Canadian bank owned financial technology startup and most recently as the head of the legal and compliance groups at a private-equity backed technology company based in Toronto, Ontario. Matt is a key figure at Wayland for transaction execution and regulatory compliance.